Suchergebnisse - "Gupta, Laxmikant"

PubPharm (14)

1

Preclinical evaluation of saroglitazar magnesium, a dual PPAR-α/γ agonist for treatment of dyslipidemia and metabolic disorders

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2018

von Patel, H. | Giri, P. | Patel, P. | +8

2

Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1

enthalten in: Cancer chemotherapy and pharmacology | 2018

von Jain, M. | Mohapatra, J. | Bandhyopadhyay, D. | +16

3

Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1

enthalten in: Cancer chemotherapy and pharmacology | 2018

von Jain, M. | Mohapatra, J. | Bandhyopadhyay, D. | +16

4

Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1

enthalten in: Cancer chemotherapy and pharmacology | 2018

von Jain, M. | Mohapatra, J. | Bandhyopadhyay, D. | +16

5

Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1

enthalten in: Cancer chemotherapy and pharmacology | 2018

von Jain, M. | Mohapatra, J. | Bandhyopadhyay, D. | +16

6

Magnetic resonance imaging findings in Tay-Sachs disease

enthalten in: Neurology India | 2018

von Gupta, L. | Mirza, A. | Gulati, A. | +1

7

Consequences of daily corticosteroid dosing with or without pre-treatment with quinidine on the in vivo cytochrome P450 2D (CYP2D) enzyme in rats : effect on O-demethylation activity of dextromethorphan and expression levels of CYP2D1 mRNA

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2018

von Giri, P. | Delvadia, P. | Gupta, L. | +5

8

Consequences of daily corticosteroid dosing with or without pre-treatment with quinidine on thein vivocytochrome P450 2D (CYP2D) enzyme in rats: effect on O-demethylation activity of dextromethorphan and expression levels of CYP2D1 mRNA

enthalten in: Xenobiotica | 2018

von Giri, P. | Delvadia, P. | Gupta, L. | +5

9

Preclinical evaluation of saroglitazar magnesium, a dual PPAR-α/γagonist for treatment of dyslipidemia and metabolic disorders

enthalten in: Xenobiotica | 2018

von Patel, H. | Giri, P. | Patel, P. | +8

10

'Trident sign' in pelvis : sinister sign with poor prognosis

enthalten in: BMJ case reports | 2017

von Gupta, L. | Yadav, M. | Thulkar, S.